Chinese biotech aims to finish trials by 2028 for spray with Wegovy active ingredient

Chinese biotech aims to finish trials by 2028 for spray with Wegovy active ingredient

Shanghai Shiling Pharmaceutical is aiming to complete global clinical trials by 2028 for an experimental weight-management spray that uses the same active ingredient as Novo Nordisk's Wegovy obesity injection, the Chinese biotech said on Tuesday.

Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China

A Chinese biotechnology company, Shanghai Shiling Pharmaceutical, plans to complete clinical trials by 2028 for a weight-loss nasal spray that uses semaglutide, the same active ingredient as Danish drugmaker Novo Nordisk’s … The post Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China appeared first on Scandasia.